Lunai Bioworks (LNAI) Current Assets (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Current Assets of $3.7 million for Q1 2026, up 1.76% year-over-year from $3.7 million in Q1 2025, and up 625.51% quarter-over-quarter from $514489.0 in Q4 2025.
Lunai Bioworks (LNAI) Current Assets (2011 - 2026) Analysis & Trends
Lunai Bioworks' Current Assets history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Current Assets rose 1.76% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 1.76% YoY), while the FY2025 annual figure was $1.0 million, down 47.61% from the prior year.
- Current Assets for Q1 2026 stood at $3.7 million, up from $514489.0 in the prior quarter.
- The five-year high for Current Assets was $11.7 million in Q1 2022, with the low at $514489.0 in Q4 2025.
- The 5-year median for Current Assets is $2.4 million (2023), against an average of $3.7 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets tumbled 76.56% in 2023, then soared 200.68% in 2025.
- Lunai Bioworks' Current Assets stood at $5.4 million in 2022, then tumbled by 55.41% to $2.4 million in 2023, then fell by 28.92% to $1.7 million in 2024, then slumped by 69.88% to $514489.0 in 2025, then surged by 625.51% to $3.7 million in 2026.
- Business Quant data shows LNAI's Current Assets at $3.7 million in Q1 2026, $514489.0 in Q4 2025, and $800360.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 1.76 Bn |
| 10 | Lunai Bioworks | 6.94 Mn | 3.78 Mn | 20,942.00 | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 514,489.00 |
| Sep 30, 2025 | 800,360.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 2.57 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 8.13 Mn |
| Jun 30, 2022 | 9.57 Mn |
| Mar 31, 2022 | 11.70 Mn |
| Dec 31, 2021 | 14.62 Mn |
| Sep 30, 2021 | 15.46 Mn |
| Jun 30, 2021 | 20.90 Mn |